Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

< b > Conditions < /b > :   Neoplasm Metastasis;   Sarcoma;   Neoplasms, Germ Cell and Embryonal;   Melanoma < br/ > < b > Interventions < /b > :   Drug: decitabine (DAC);   Drug: Tetrahydrouridine (THU);   Drug: Celecoxib < br/ > < b > Sponsor < /b > :   National Cancer Institute (NCI) < br/ > < b > Recruiting < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials